Sophim completes €20m funding to double production capacity

French natural cosmetic ingredient maker Sophim has completed a €20m ($21.43m) funding round to double its production capacity and accelerate international sales.

Existing investor Smalt Capital has injected a further €4.5m that will be used to boost output from Sophim’s facilities in Peyruis, France and Almeria, Spain.

One of the Alpes de Haute Provence company’s flagship products is Phytosqualan, is a squalane that is 100% of vegetable origin, made from olives.

Developed in the company's R&D laboratory, the production of squalane follows the principles of the circular economy, by recovering olive fatty acids.

“In our rapidly growing environment, sustainable development must remain a priority,” said Sophim managing director Alexis Margnat. “Ecological responsibility is at our heart and has always been an essential element in the development of our business project.”

Marseille-based Smalt Capital has been investing in Sophim – which was founded in 1996 - since 2014.

“We are proud to continue the adventure with Sophim,” said Julien Jorge, manager at Smalt Capital.

“Beyond purely financial criteria, the human, collective and ecological dimension occupies a central place in Sophim’s corporate culture. We are confident in the company's ability to build on its competitive advantages to establish itself as a leader in its field," he added.

Sophim president Jacques Margnat said: "This investment will allow us to double our production capacity at our two industrial sites, to meet strong demand for our products, especially internationally.”

Latest Issues

SCS Formulate 2024

Coventry Building Society Arena, UK
12th - 13th November 2024

Making Cosmetics 2024

Allianz MiCo, Hall 4, Viale L. Scarampo, Milano, Italy
20-21 November 2024